Hao-Zhe Lu

Clinical outcomes and prognostic factors after first- and second-line immunotherapy in a cohort of 57 patients with refractory autoimmune encephalitis

Refractory autoimmune encephalitis (AE) is a severe condition with limited real-world evidence on treatment outcomes and prognostic factors. This study evaluated clinical outcomes and factors associated with 6-month functional recovery in a strictly defined refractory AE cohort. This single-center retrospect...